The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities
Oligo-arginines are cell-penetrating peptides and find use as carriers for transportation of various membrane-impermeable biopharmaceuticals into target cells. We have found that oligo-arginines of a length of 4–10 amino acids, but especially (Arg) 8, are able to inhibit the major intracellular prot...
Gespeichert in:
Veröffentlicht in: | European journal of pharmaceutics and biopharmaceutics 2009-05, Vol.72 (1), p.219-225 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Oligo-arginines are cell-penetrating peptides and find use as carriers for transportation of various membrane-impermeable biopharmaceuticals into target cells. We have found that oligo-arginines of a length of 4–10 amino acids, but especially (Arg)
8, are able to inhibit the major intracellular proteolytic system, the proteasome, with mixed-type inhibition characteristics. The IC
50 values of (Arg)
8 for the proteasomal chymotrypsin-like and caspase-like activities are approximately 100 and 200
nM, respectively. The inhibition of the trypsin-like activity never exceeds 50% even at micromolar concentrations. (Arg)
8 also inhibits 20S proteasome/PA28 complexes as well as 26S proteasomes, although with a decreased efficiency. Due to its cell membrane-penetrating capability, incubation of HeLa cells in the presence of (Arg)
8 resulted in an impaired activity of proteasomes going along with an accumulation of high-molecular mass ubiquitin-conjugated proteins, the preferred substrates of 26S proteasomes. The
in vivo susceptibility of the three proteasome activities resembles that found
in vitro with chymotrypsin-like
>
caspase-like
>
trypsin-like activities. Since inhibition of the proteasome system might affect fundamental basic cellular processes but on the other side might also prevent the degradation of a proteinacous cargo, we suggest that this proteasome inhibitory activity should be taken into account when oligo-arginines are being considered for use as vectors for the intracellular delivery of pharmaceuticals. |
---|---|
ISSN: | 0939-6411 1873-3441 |
DOI: | 10.1016/j.ejpb.2008.10.016 |